News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,610 Results
Type
Article (47014)
Company Profile (497)
Press Release (686099)
Section
Business (216798)
Career Advice (2347)
Deals (36948)
Drug Delivery (99)
Drug Development (84856)
Employer Resources (178)
FDA (16808)
Job Trends (15638)
News (364411)
Policy (34098)
Tag
Academia (2816)
Alliances (52921)
Alzheimer's disease (1331)
Approvals (16729)
Artificial intelligence (160)
Bankruptcy (365)
Best Places to Work (12203)
Biotechnology (364)
Breast cancer (175)
Cancer (1346)
Cardiovascular disease (116)
Career advice (1958)
Cell therapy (289)
Clinical research (67439)
Collaboration (474)
Compensation (248)
COVID-19 (2664)
C-suite (118)
Data (1370)
Diabetes (169)
Diagnostics (6553)
Earnings (88236)
Employer resources (157)
Events (118527)
Executive appointments (373)
FDA (17448)
Funding (428)
Gene therapy (211)
GLP-1 (655)
Government (4558)
Healthcare (20020)
Infectious disease (2753)
Inflammatory bowel disease (121)
Interviews (379)
IPO (16902)
Job creations (3858)
Job search strategy (1675)
Layoffs (457)
Legal (8199)
Lung cancer (192)
Manufacturing (205)
Medical device (13914)
Medtech (13919)
Mergers & acquisitions (20159)
Metabolic disorders (465)
Neuroscience (1663)
NextGen Class of 2024 (7155)
Non-profit (4844)
Northern California (1661)
Obesity (269)
Opinion (216)
Patents (115)
People (60859)
Phase I (21136)
Phase II (29738)
Phase III (22027)
Pipeline (506)
Postmarket research (2665)
Preclinical (9126)
Radiopharmaceuticals (255)
Rare diseases (270)
Real estate (6351)
Regulatory (22784)
Research institute (2556)
Resumes & cover letters (390)
Southern California (1450)
Startups (3859)
United States (15329)
Vaccines (607)
Weight loss (202)
Date
Today (168)
Last 7 days (685)
Last 30 days (3044)
Last 365 days (37231)
2024 (35982)
2023 (41875)
2022 (53244)
2021 (57877)
2020 (56484)
2019 (49665)
2018 (37555)
2017 (34348)
2016 (33959)
2015 (40175)
2014 (33837)
2013 (28950)
2012 (31128)
2011 (31649)
2010 (29690)
Location
Africa (809)
Arizona (213)
Asia (41003)
Australia (6901)
California (3793)
Canada (1403)
China (295)
Colorado (171)
Connecticut (182)
Europe (91148)
Florida (513)
Georgia (138)
Illinois (407)
Indiana (222)
Kansas (100)
Maryland (635)
Massachusetts (3023)
Michigan (185)
Minnesota (297)
New Jersey (1087)
New York (1072)
North Carolina (815)
Northern California (1661)
Ohio (150)
Pennsylvania (908)
South America (1224)
Southern California (1450)
Texas (548)
Utah (109)
Washington State (407)
733,610 Results for "lead therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236
CERo Therapeutics Holdings, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announced it successfully executed pre-IND manufacturing activities for its lead therapeutic, CER-1236.
June 13, 2024
·
4 min read
Press Releases
Secretome Therapeutics, Inc. Announces Composition of Matter Patents for Lead Assets STM-01 and STM-21
October 28, 2024
·
2 min read
Strategic Advisory for Leading Therapeutics Innovation Inc. (SALTI) Announces Launch to Set New Standard in Life Sciences Commercialization Management Consulting
Strategic Advisory for Leading Therapeutics Innovation Inc. (SALTI) is proud to announce its official launch, poised to set a new standard in life sciences consulting.
April 30, 2024
·
3 min read
Press Releases
KBI Biopharma to Lead Development and Manufacturing of Alanis Therapeutics’ Antagonistic Antibody Candidate
December 3, 2024
·
4 min read
Press Releases
Qnovia, Inc. Raises $16 Million in Series B Financing to Advance Lead Asset RespiRx™ Nicotine Inhaler as a Prescription Smoking Cessation Therapy
December 10, 2024
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Drug Development
Eyenovia Shares Plummet 70% After It Drops Lead Program
Eyenovia’s stock craters to its lowest point in its six-year lifespan as a public company following the biotech’s termination of its lead program in pediatric progressive myopia due to lack of efficacy.
November 15, 2024
·
2 min read
·
Heather McKenzie
Press Releases
Eikonizo Therapeutics Announces Investment by Novo Nordisk; Advancing Lead Candidate EKZ-102 Toward Clinical Development
December 10, 2024
·
5 min read
Press Releases
Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
November 20, 2024
·
5 min read
Biotech Beach
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting
Fulgent Pharma, a subsidiary of Fulgent Genetics, Inc. and a leading nanobiotechnology company specializing in innovative cancer therapeutics, announced that Phase 1 clinical data on its lead therapeutic development candidate, FID-007, to treat Head and Neck cancer, will be presented at the American Society for Clinical Oncology Annual Meeting on June 2, 2024 in Chicago, Illinois.
May 24, 2024
·
5 min read
1 of 73,361
Next
